- Remission after Rituximab Therapy in Refractory Myasthenia Gravis
-
Park JM, Lee HC, Park JS
- KMID: 2370964
- J Korean Neurol Assoc.
- 2017 Feb;35(1):26-29.
- doi: 10.17340/jkna.2017.1.5
Myasthenia gravis (MG) is estimated to be refractory in approximately 10% of patients with generalized MG. A 35-year-old man was diagnosed as generalized MG with thymoma. Despite aggressive immunotherapies, his... -
- CITED
-
- Close
- SHARE
-
- Close
- Is there a relationship between the infusion-related reaction and effect of rituximab in the treatment of patients with diffuse large B-cell lymphoma?
-
Park SG
- KMID: 2457306
- Korean J Intern Med.
- 2019 Jul;34(4):775-776.
- doi: 10.3904/kjim.2019.182
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A new era of B cell lymphoma treatment by using monoclonal antibody: Rituximab (anti-CD20 antibody)
-
Cho SG
- KMID: 2256615
- Korean J Med.
- 2006 Aug;71(2):124-131.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab
-
Tendas A, Niscola P, Scaramucci L, Cupelli L, Perrotti A, de Fabritiis P
- KMID: 2309217
- Blood Res.
- 2016 Jun;51(2):137-138.
- doi: 10.5045/br.2016.51.2.137
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Rituximab Treatment for Polyneuropathy Induced by an Immune Checkpoint Inhibitor
-
Shin HR, Kang DW, Kim EY, Kim TM, Lee ST
- KMID: 2435845
- J Korean Neurol Assoc.
- 2018 Nov;36(4):329-332.
- doi: 10.17340/jkna.2018.4.11
Immune checkpoint inhibitor is associated with variety of immune-related adverse events. We present a case of polyneuropathy induced by immune checkpoint inhibitor, which was refractory to steroid and immunoglobulin. While... -
- CITED
-
- Close
- SHARE
-
- Close
- Rituximab in Patients with Inflammatory Myopathies
-
Kang SW
- KMID: 2222991
- J Rheum Dis.
- 2013 Dec;20(6):345-347.
- doi: 10.4078/jrd.2013.20.6.345
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Prolonged Hypogammaglobulinemia after Rituximab-Containing Chemotherapy in a Patient with Lymphoma
-
Noh HJ, Gong BH, Kim YS, Jung YH, Woo IS, Han CW
- KMID: 2269250
- Korean J Med.
- 2014 Sep;87(3):357-362.
- doi: 10.3904/kjm.2014.87.3.357
Rituximab, an anti-CD20 monoclonal antibody, is an effective target agent against the B lymphocytes in B-cell lymphoid malignancies and various lymphoproliferative diseases. Moreover, the toxicity of rituximab is less severe... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Organizing Pneumonia Associated with Rituximab
-
Maeng CH, Chin SO, Yang BH, Kim SY, Youn HJ, Cho KS, Baek SK, Lee S
- KMID: 2166102
- Cancer Res Treat.
- 2007 Jun;39(2):88-91.
Rituximab is a human/murine chimeric anti-CD20 mono- clonal antibody used to treat CD20-positive B-cell non- Hodgkin's lymphoma (NHL). Although most of the adverse effects associated with rituximab are usually reversible... -
- CITED
-
- Close
- SHARE
-
- Close
- Catastrophic Antiphospholipid Syndrome Associated with Systemic Lupus Erythematosus Successfully Treated with Rituximab: A Case Report
-
Shin J, Kim KN
- KMID: 2442037
- J Rheum Dis.
- 2019 Jan;26(1):74-78.
- doi: 10.4078/jrd.2019.26.1.74
The catastrophic variant of antiphospholipid syndrome (APS) is a very rare and life-threatening condition of APS. This condition is characterized by thrombosis in multiple organs within a short period of... -
- CITED
-
- Close
- SHARE
-
- Close
- Steroid Non-responsive Hashimoto's Encephalopathy Improved by Rituximab
-
Jang SH, Moon HJ, Cho YW
- KMID: 2435779
- J Korean Neurol Assoc.
- 2018 Feb;36(1):19-21.
- doi: 10.17340/jkna.2018.1.4
Hashimoto's encephalopathy is a rare autoimmune disease, with symptoms of encephalopathy and high titers of serum anti-thyroid antibodies. Current diagnostic criteria include corticosteroid responsiveness, but in some cases, they are... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of rapid desensitization for rituximab-induced delayed hypersensitivity reaction
-
Lee SH, Lee JH, Kim NH, Kang DY, Lee JY, Chung SJ, Oh JH, Kang HR
- KMID: 2444845
- Allergy Asthma Respir Dis.
- 2019 Apr;7(2):109-112.
- doi: 10.4168/aard.2019.7.2.109
Rituximab is a monoclonal antibody used for the treatment of B-cell malignancies, including diffuse large B-cell lymphoma. Infusion-related hypersensitivity reactions to rituximab is well known, and delayed hypersensitivity reactions to... -
- CITED
-
- Close
- SHARE
-
- Close
- Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
-
Palombi M, Scaramucci L, Giovannini M, Trawinska , Niscola P, de Fabritiis P
- KMID: 2172749
- Blood Res.
- 2016 Mar;51(1):66-66.
- doi: 10.5045/br.2016.51.1.66
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A case of interstitial lung diseasec caused by Rituximab in non-Hodgkin lymphoma
-
Choi YJ, Jung WJ, Oh SI, Jeon MH, Sohn HJ, Han EM, Suh C
- KMID: 2256603
- Korean J Med.
- 2006 Oct;71(4):449-455.
Rituximab targets CD20+ B cells and has been used increasingly for the treatment of B-cell Non-Hodgkin Lymphoma, alone or in combination with cytotoxic agents. Rituximab can kill CD20+cells by multiple... -
- CITED
-
- Close
- SHARE
-
- Close
- Kikuchi-Fujimoto Disease, A Possible Complication of Rituximab Treatment
-
Lee J, Chang HJ, Lee ST, Kang HG, Ha IS, Cheong HI
- KMID: 2322039
- J Korean Soc Pediatr Nephrol.
- 2012 Oct;16(2):138-141.
Rituximab, a chimeric anti-CD20 IgG1 monoclonal antibody, has been used as a rescue therapy for steroid-dependent or refractory nephrotic syndrome. However, the adverse effects of rituximab are yet to be... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Rituximab Therapy in Diffuse Alveolar Hemorrhage of Systemic Lupus Erythematosus Refractory to Steroid Pulse Therapy
-
Yim SW, Byon CK, Park JY, Lee SY, Lee SW, Chung WT
- KMID: 2222962
- J Rheum Dis.
- 2014 Aug;21(4):201-204.
- doi: 10.4078/jrd.2014.21.4.201
Rituximab is a chimeric murine-human monoclonal antibody that is directed against the specific B-cell CD20 antigen, which has recently been successfully used in active or refractory systemic lupus erythematosus (SLE)... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Anti-CD20 Monoclonal Antibody (Rituximab) on Recalcitrant Pemphigus Vulgaris
-
Kim MR, Kim SC
- KMID: 2302072
- Korean J Dermatol.
- 2008 Mar;46(3):319-324.
BACKGROUND: Pemphigus is a severe blistering disorder caused by autoantibodies to desmogleins 1 and 3. Because some patients with pemphigus never enter into remission, new immunosuppressants are warranted. Rituximab is... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Autoimmune Hemolytic Anemia Treated with Rituximab in a Child
-
Lee JH, Lee KS
- KMID: 2305222
- Korean J Hematol.
- 2006 Dec;41(4):321-325.
- doi: 10.5045/kjh.2006.41.4.321
Autoimmune hemolytic anemia (AIHA) in children usually responds well to short-term steroid therapy. However, in some cases, AIHA requires prolonged immunosuppressive therapy, with the subsequent development of severe side effects.... -
- CITED
-
- Close
- SHARE
-
- Close
- Two cases of idiopathic membranous nephropathy treated with rituximab
-
Yoon JY, Han ST, Cho A, Jang HR, Lee JE, Huh W, Kim DJ, Oh HY, Kim YG
- KMID: 2224309
- Kidney Res Clin Pract.
- 2013 Sep;32(3):138-141.
Idiopathic membranous nephropathy is a common cause of nephrotic syndrome, and has been reported as a cause of idiopathic primary glomerulonephropathy in up to 90% of patients. However, the treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Rituximab Use in Rheumatoid Arthritis Following Anti-TNF-Associated Tuberculosis
-
Kim KH, Moon KW, Heo JW, Lee WH, Lee SH, Jeong CM, Park HS
- KMID: 2223108
- J Rheum Dis.
- 2012 Apr;19(2):100-103.
- doi: 10.4078/jrd.2012.19.2.100
Rituximab has been shown to be effective in rheumatoid arthritis (RA) and is recommended for patients exhibiting an inadequate response to tumor necrosis factor (TNF) inhibitors. To date, there have... -
- CITED
-
- Close
- SHARE
-
- Close
- Radioimmunotherapy with 131I-Rituximab in a Patient with Diffuse Large B-Cell Lymphoma Relapsed After Treatment with 90Y-Ibritumomab Tiuxetan
-
Kang GW, Kang HJ, Shin DY, Gu HR, Choi HS, Lim SM
- KMID: 2313169
- Nucl Med Mol Imaging.
- 2013 Dec;47(4):281-284.
We report a case that demonstrates the efficacy of radioimmunotherapy (RIT) with radioiodinated rituximab (131I-rituximab) for relapsed diffuse large B-cell lymphoma (DLBCL). A 79-year-old male patient with DLBCL initially achieved... -
- CITED
-
- Close
- SHARE
-
- Close
